Login
Password
Remember Me
Vivet Therapeutics receives €4.9 million to advance development of a gene therapy for the treatment of cerebrotendinous xanthomatosis Funding from French...
AiCuris and the German Center for Infection Research (DZIF) sign Collaboration and License Option Agreement ©DZIF AiCuris Anti-infective Cures AG and...
Using artificial intelligence to discover therapeutic antibodies Former EMBL staff scientist founds a start-up – DenovAI – for broader, faster and...
More articles from NEWS
True cost of sickle cell disease: $1.5 billion in lost productivity per year Sickle cell disease causes $1.5 billion in lost...
Record financing for the regenerative medicine sector through Q3 2020 The regenerative medicine sector attracted $15.9 billion in financing through just...
How to increase the number of European-based ATMP clinical trials? The latest report published by the Alliance for Regenerative Medicine (ARM),...
More articles from ANALYSES
An epigenome editing toolkit to dissect the mechanisms of gene regulation A study from the Hackett group at EMBL Rome led...
New approach to single-cell RNA structure sequencing unveils biomarkers for human development and disease Different cells have different RNA structures and...
NIH study shows how genes in retina get regulated during development Genome topology map of human retina development lays foundation for...
More articles from SCIENTIFIC NEWS